Sangamo Therapeutics Inc
OTC:SGMOQ
Sangamo Therapeutics Inc
OTC:SGMOQ
Price:
0.161
USD
0.94%
Market Closed
Market Cap:
$66.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sangamo Therapeutics Inc
OTC:SGMOQ
|
US |
|
Nippon Felt Co Ltd
TSE:3512
|
JP |
|
CanXGold Mining Corp.
F:L93
|
CA |
|
B
|
Blue Moon Metals Inc
XBER:8SX
|
CA |
|
D
|
DiaSorin SpA
SWB:34D
|
IT |
|
Kineta Inc
OTC:KANT
|
US |
|
C
|
Citigold Corporation Ltd
F:CHP
|
AU |
|
W
|
Westag AG
F:WUG3
|
DE |
|
LeTech Corp
TSE:3497
|
JP |
|
Earthwise Minerals Corp
OTC:EWISF
|
CA |
|
S
|
SPEL Ltd
KAR:SPEL
|
PK |
|
T
|
Third Age Health Services Ltd
NZX:TAH
|
NZ |
|
Y
|
Yiren Digital Ltd
SWB:19YA
|
CN |
|
Kronos Advanced Technologies Inc
OTC:KNOS
|
US |
|
O
|
Onxeo SA
XBER:C4X
|
FR |
|
Pure Foods Tasmania Ltd
F:C9CB
|
AU |
|
C
|
Cabo Catoche Corp
OTC:MDRA
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SGMOQ's stock price target?
Not Available
SGMOQ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sangamo Therapeutics Inc?
Projected CAGR
90%
90%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 90%.
